Komori
Financial results presentation4249MORIROKU COMPANY,LTD.Materials and Chemicals

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027

Revenue, operating income and ordinary income exceeded the year-earlier period, partly due to the benefit of consolidating the ReNova business. Net income increased substantially, including a gain on negative goodwill arising from making the business a consolidated subsidiary.

Worth reading
28Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
143
¥100 million (year-on-year increase in net sales)
Wording
Definitive
How definitive the wording is.

Contents of this document

Financial results presentationFirst quarter of the fiscal year ending March 20273 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥48,191 million+42.5%
Operating profit¥2,297 million+113.4%
Ordinary income¥2,297 million+153.6%
Net income¥3,498 million+560.5%
Operating profit margin
rate_pct4.8
yoy_change_points1.6
Results for the three months of the current quarter
Net Sales
¥48,191 million
Operating profit
¥2,297 million
Ordinary income
¥2,297 million
Net income
¥3,498 million
Full-year earnings forecast
Net Sales
¥194,600 million
Operating profit
¥6,500 million
Ordinary income
¥5,600 million
Net income
¥5,400 million
What the company explained in this material
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate (US dollar)¥145.0 per US dollar
Exchange rate (Chinese yuan)¥19.5 per Chinese yuan
New initiatives
  • Consolidation of the ReNova business acquired in April 2026 (森六ReNova株式会社 and its 2 subsidiaries)
Segment results
  • Resin-Processed Products Business
    Net Sales¥41,697 million
    Year-on-Year Change in Revenue (%)50.5
    Operating profit¥2,040 million
    Operating profit year-on-year_pct65.1
  • Chemicals Business
    Net Sales¥6,494 million
    Year-on-Year Change in Revenue (%)6.3
    Operating profit¥724 million
    Operating profit year-on-year_pct157.1
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFirst quarter of the fiscal year ending March 2027
Net Sales¥48,191 million (YoY +42.5%)
Operating profit¥2,297 million (YoY +113.4%)
Ordinary income¥2,297 million (YoY +153.6%)
Net income¥3,498 million (YoY +560.5%)
Operating profit marginrate_pct 4.8 / yoy_change_points 1.6
Results for the three months of the current quarterNet Sales ¥48,191 million / Operating profit ¥2,297 million / Ordinary income ¥2,297 million / Net income ¥3,498 million
Full-year earnings forecastNet Sales ¥194,600 million / Operating profit ¥6,500 million / Ordinary income ¥5,600 million / Net income ¥5,400 million
Segment resultsSegment Resin-Processed Products Business / Net Sales ¥41,697 million / Year-on-Year Change in Revenue (%) 50.5 / Operating profit ¥2,040 million / Operating profit year-on-year_pct 65.1, Segment Chemicals Business / Net Sales ¥6,494 million / Year-on-Year Change in Revenue (%) 6.3 / Operating profit ¥724 million / Operating profit year-on-year_pct 157.1
Assumptions Underlying the Business OutlookExchange rate (US dollar) ¥145.0 per US dollar / Exchange rate (Chinese yuan) ¥19.5 per Chinese yuan
New initiativesConsolidation of the ReNova business acquired in April 2026 (森六ReNova株式会社 and its 2 subsidiaries)
Items this document does not state (19)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeKey KPIsUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue benefited from the consolidation of the ReNova business acquired in April 2026. Operating income benefited from the consolidation of the ReNova business, increased sales in the Chemicals business and the effects of price revisions. Ordinary income benefited from the foreign exchange loss in the year-earlier period turning into a foreign exchange gain. Net income benefited from the gain on negative goodwill arising from making the ReNova business a consolidated subsidiary.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 | MORIROKU COMPANY,LTD. (4249) timely disclosure | Komori